FDA approves 3rd COVID-19 vaccine shot for those with weak immune systems
A select group of vaccinated immunocompromised New Yorkers may soon be getting a third shot. The FDA has authorized a booster shot of the COVID-19 Pfizer and Moderna vaccines.
The FDA is advising a distinct group of immunocompromised people to get a booster shot. If they have a compromised immune system, an additional booster shot of the vaccine may help.
Specifically, this includes anyone who is an organ transplant recipient or if that person has been diagnosed with specific health conditions that have an equivalent level of immunocompromise.
The FDA says this small vulnerable group has a reduced ability to fight infections and other diseases, and they are especially vulnerable to infections, including COVID-19.
The FDA insists other fully vaccinated individuals who are not immunocompromised do not need an additional vaccine dose right now.
For those who will be eligible for the booster shot, the recommendation is to receive the third dose at least 28 days after the second dose. There’s no word yet on exactly when the booster doses will be administered.